التأثيرات الناتجة عن استخدام عقاري الديكلوفيناك والسيبروفلوكساسين على الكبد والكلى لدى الجرذان

Kelleni MT. Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes. Biomedicine & Pharmacotherapy. 2021 Jan 1;133:110982. https://doi.org/10.1016/j.biopha.2020.110982

Altman R, Bosch B, Brune K, Patrignani P, Young C. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs. 2015 May;75(8):859-77. https://doi.org/10.1007/s40265-015-0392-z

Mishra N, Mahamuni A. A COMPARATIVE STUDY OF DICLOFENAC SODIUM WITH PIROXICAM IN PATIENTS UNDERGOING SURGICAL REMOVAL OF THIRD MOLAR. Journal of Critical Reviews. 2020;7(7):669-71. https://doi.org/10.31838/jcr.07.07.122

Ptaszyńska N, Gucwa K, Olkiewicz K, Heldt M, Serocki M, Stupak A, Martynow D, Dębowski D, Gitlin-Domagalska A, Lica J, Łęgowska A. Conjugates of ciprofloxacin and levofloxacin with cell-penetrating peptide exhibit antifungal activity and mammalian cytotoxicity. International journal of molecular sciences. 2020 Jan;21(13):4696. https://doi.org/10.3390/ijms21134696.

Jaber DF, Jallad MA, Abdelnoor AM. The effect of ciprofloxacin on the growth of B16F10 melanoma cells. Journal of cancer research and therapeutics. 2017 Oct 1;13(6):956.

Eticha T, Kahsay G, Asefa F, Hailu T, Gebretsadik H, Gebretsadikan T, Thangabalan B. Chemometric-Assisted spectrophotometric method for the simultaneous determination of ciprofloxacin and doxycycline hyclate in pharmaceutical formulations. Journal of analytical methods in chemistry. 2018 Dec 18;2018. https://doi.org/10.1155/2018/9538435.

Phang-Lyn S, Llerena VA. Biochemistry, Biotransformation. StatPearls [Internet]. 2020 Sep 2.

Raunio H, Kuusisto M, Juvonen RO, Pentikäinen OT. Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes. Frontiers in pharmacology. 2015 Jun 12;6:123. https://doi.org/10.3389/fphar.2015.00123

Matias M, Canário C, Silvestre S, Falcão A, Alves G. Cytochrome P450-mediated toxicity of therapeutic drugs. Cytochrome P450 Enzymes: Biochemistry, Pharmacology and Health Implications. 2014:13-50.

Ohyama K, Murayama N, Shimizu M, Yamazaki H. Drug interactions of diclofenac and its oxidative metabolite with human liver microsomal cytochrome P450 1A2-dependent drug oxidation. Xenobiotica. 2014 Jan 1;44(1):10-6. https://doi.org/10.3109/00498254.2013.806837.

Sychev DA, Ashraf GM, Svistunov AA, Maksimov ML, Tarasov VV, Chubarev VN, Otdelenov VA, Denisenko NJ, Barreto GE, Aliev G. The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo. Drug design, development and therapy. 2018;12:1147. https://doi.org/10.2147/DDDT.S149069.

Tornio A, Filppula AM, Niemi M, Backman JT. Clinical studies on drug–drug interactions involving metabolism and transport: methodology, pitfalls, and interpretation. Clinical Pharmacology & Therapeutics. 2019 Jun;105(6):1345-61. https://doi.org/10.1002/cpt.1435.

Deodhar, M., Al Rihani, S. B., Arwood, M. J., Darakjian, L., Dow, P., Turgeon, J., & Michaud, V. (2020). Mechanisms of CYP450 inhibition: understanding drug-drug interactions due to mechanism-based inhibition in clinical practice. Pharmaceutics, 12(9), 846. https://doi.org/10.3390/pharmaceutics12090846.

Spina E, Barbieri MA, Cicala G, de Leon J. Clinically relevant interactions between atypical antipsychotics and anti-infective agents. Pharmaceuticals. 2020 Dec;13(12):439. https://doi.org/10.3390/ph13120439.

Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, Lyu Y, Chen X, Liu K, Yu AM. Current trends in drug metabolism and pharmacokinetics. Acta Pharmaceutica Sinica B. 2019 Nov 1;9(6):1113-44. https://doi.org/10.1016/j.apsb.2019.10.001.

Zhong ZY, Sun BB, Shu N, Xie QS, Tang XG, Ling ZL, Wang F, Zhao KJ, Xu P, Zhang M, Li Y. Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity. Acta Pharmacologica Sinica. 2016 Jul;37(7):1002-12. https://doi.org/10.1038/aps.2016.54

Aydin G, Gökçimen A, Öncü M, Çicek E, Karahan N, Gökalp O. Histopathologic changes in liver and renal tissues induced by different doses of diclofenac sodium in rats. Turkish journal of veterinary and animal sciences. 2003 Oct 15;27(5):1131-40.

Adeyemi WJ, Olayaki LA. Diclofenac–induced hepatotoxicity: Low dose of omega-3 fatty acids have more protective effects. Toxicology reports. 2018 Jan 1;5:90-5. https://doi.org/10.1016/j.toxrep.2017.12.002.

Alabi QK, Akomolafe RO. Kolaviron diminishes diclofenac-induced liver and kidney toxicity in wistar rats via suppressing inflammatory events, upregulating antioxidant defenses, and improving hematological indices. Dose-Response. 2020 Mar 2;18(1):1559325819899256. https://doi.org/10.1177/1559325819899256

Sharef AY, Hamdi BA, Alnajar ZA. Histopathological aspects of co-administration of dexamethasone and diclofenac sodium on male albino rats. Zanco Journal of Medical Sciences (Zanco J Med Sci). 2020 Aug 30;24(2):236-45. https://doi.org/10.15218/zjms.2020.028

SABEEH SI, SALIH RA, BDEWI SY, HASAN MS. Effects of ciprofloxacin on liver and kidney functions and histopathological features in rats. International Journal of Pharmaceutical Research. 2019 Oct;11(1).

Dogan Z, Elbe H, Taslidere EL, Soysal H, Cetin AY, Demirtas S. Effects of ciprofloxacin on fetal rat liver during pregnancy and protective effects of quercetin. Biotechnic & Histochemistry. 2017 Oct 3;92(7):481-6. https://doi.org/10.1080/10520295.2017.1356469

Buschmann J. The OECD guidelines for the testing of chemicals and pesticides. Teratogenicity testing. 2013:37-56. https://doi.org/10.1007/978-1-62703-131-8_4

Abd El-Rhaman HA, Mohamed ZA, Sultan AR, Tawfik AR. Assessment of the Effect of Non-steroidal Anti-inflammatory Drug (Diclofenac Potassium) on the Pregnant Rats and their Fetuses.

Ravishankar AC, Gandigawad P, Hiremath SV. EFFECT OF CIPROFLOXACI O ACUTE AD SUBACUTE I FLAMMATIO I WISTAR RATS.

Ibrahim ZS, Ahmed MM, El-Shazly SA, Alkafafy ME. Effects of camel milk on drug metabolising cytochrome p450 enzymes expressions in rats. Journal of Camel Practice and Research. 2016;23(1):25-32. https://doi.org/10.5958/2277-8934.2016.00004.7.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. methods. 2001 Dec 1;25(4):402-8. https://doi.org/10.1006/meth.2001.1262.

Coakes SJ, Steed L. SPSS: Analysis without anguish using SPSS version 14.0 for Windows. John Wiley & Sons, Inc.; 2009 Sep 30.

Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & therapeutics. 2013 Apr 1;138(1):103-41. https://doi.org/10.1016/j.pharmthera.2012.12.007.

Ansede JH, Thakker DR. High‐throughput screening for stability and inhibitory activity of compounds toward cytochrome P450‐mediated metabolism. Journal of pharmaceutical sciences. 2004 Feb 1;93(2):239-55. https://doi.org/10.1002/jps.10545.

Chopra N, Ruan CJ, McCollum B, Ognibene J, Shelton C, de Leon J. High doses of drugs extensively metabolized by CYP3A4 were needed to reach therapeutic concentrations in two patients taking inducers. Revista Colombiana de Psiquiatría (English ed.). 2020 Apr 1;49(2):83-94. https://doi.org/10.1016/j.rcpeng.2020.04.002.

Daly AK, Rettie AE, Fowler DM, Miners JO. Pharmacogenomics of CYP2C9: functional and clinical considerations. Journal of personalized medicine. 2018 Mar;8(1):1. https://doi.org/10.3390/jpm8010001

Miners JO, Birkett DJ. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. British journal of clinical pharmacology. 1998 Jun;45(6):525-38. https://doi.org/10.1046/j.1365-2125.1998.00721.x

Iqbal Z, Khan A, Naz A, Khan JA, Khan GS. Pharmacokinetic interaction of ciprofloxacin with diclofenac. Clinical drug investigation. 2009 Apr;29(4):275-81. https://doi.org/10.2165/00044011-200929040-00006

Bhogaraju A, Nazeer S, Al-Baghdadi Y, Rahman M, Wrestler F, Patel N. Diclofenac-associated hepatitis. Southern medical journal. 1999 Jul 1;92(7):711-3. https://doi.org/10.1097/00007611-199907000-00011

Rossi E, Ferraccioli GF, Cavalieri F, Menta R, Dall’Aglio PP, Migone L. Diclofenac-associated acute renal failure. Nephron. 1985;40(4):491-3. https://doi.org/10.1159/000183528.

Alan C, Koçoğlu H, Ersay AR, Ertung Y, Kurt HA. Unexpected severe hepatotoxicity of ciprofloxacine: two case reports. Drug and chemical toxicology. 2011 Apr 1;34(2):189-91. https://doi.org/10.3109/01480545.2010.495392.

George MJ, Dew RB, Daly JS. Acute renal failure after an overdose of ciprofloxacin. Archives of internal medicine. 1991 Mar 1;151(3):620-.https://doi.org/10.1001/archinte.1991.00400030146039

Aydin G, Gökçimen A, Öncü M, Çicek E, Karahan N, Gökalp O. Histopathologic changes in liver and renal tissues induced by different doses of diclofenac sodium in rats. Turkish journal of veterinary and animal sciences. 2003 Oct 15;27(5):1131-40.

Baykal A, Sarigül F, Süleymanlar G, Moreira PI, Perry G, Smith MA, Alicigüzel Y. Ciprofloxacin does not exert nephrotoxicity in rats. American Journal of Infectious Diseases. 2005(1: 3):145-8. https://doi.org/10.3844/ajidsp.2005.145.148

Başaran A, Erol K, Başaran N, Güneş HV, Acikalin E, Timuralp G, Değirmenci I, Çakmak EA, Tomatir AG. Effects of ciprofloxacin on chromosomes, and hepatic and renal functions in rats. Chemotherapy. 1993;39(3):182-8. https://doi.org/10.1159/000239124

Feng S, He X. Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity. Current drug metabolism. 2013 Nov 1;14(9):921-45. https://doi.org/10.2174/138920021131400114.